SEC Form 4 · accession 0001209191-15-049082
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Caesar J Belbel
Officer — COO, CLO, and Secretary
Period of report
Jun 1, 2015
Accepted (ET)
Jun 2, 2015 · 5:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2015 | A | 50,000 | $0.00 | A | 59,201 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F116,667 shares shall vest on each of 06/01/2016 and 06/01/2017; 16,666 shares shall vest on 06/01/2018.